See-Tarn相关文献与解析，生知库 | 链接生命科学的每一步

Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19

可溶性野生型ACE2分子能够抑制新型SARS-CoV-2变种，是一种潜在的抗病毒策略，可用于减轻COVID-19的疾病严重程度。

Ameratunga, Rohan; Mears, Emily; Leung, Euphemia; Snell, Russell; Woon, See-Tarn; Kelton, William; Medlicott, Natalie; Jordan, Anthony; Abbott, William; Steele, Richard; Rolleston, William; Longhurst, Hilary; Lehnert, Klaus

微生物学

SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?

SARS-CoV-2 Omicron：是漫长疫情隧道尽头的曙光，还是免疫缺陷患者的又一次虚假希望？

期刊:Journal of Allergy and Clinical Immunology-In Practice

影响因子:6.6

doi:10.1016/j.jaip.2022.06.011

Ameratunga, Rohan; Leung, Euphemia; Woon, See-Tarn; Chan, Lydia; Steele, Richard; Lehnert, Klaus; Longhurst, Hilary

First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Hypersensitivity Reaction

首例确诊的致命性暴发性坏死性嗜酸性粒细胞性心肌炎病例，发生于接种辉瑞-BioNTech mRNA COVID-19疫苗（BNT162b2，Comirnaty）首剂后：一种极其罕见的特异性超敏反应

期刊:Journal of Clinical Immunology

影响因子:5.7

doi:10.1007/s10875-021-01187-0

Ameratunga, Rohan; Woon, See-Tarn; Sheppard, Mary N; Garland, Jack; Ondruschka, Benjamin; Wong, Christopher X; Stewart, Ralph A H; Tatley, Michael; Stables, Simon R; Tse, Rexson D

Droplet digital PCR for identifying copy number variations in patients with primary immunodeficiency disorders

液滴数字PCR用于识别原发性免疫缺陷疾病患者的拷贝数变异

期刊:Clinical and Experimental Immunology

影响因子:3.8

doi:10.1093/cei/uxab034

Woon, See-Tarn; Mayes, Julia; Quach, Alexander; Longhurst, Hilary; Ferrante, Antonio; Ameratunga, Rohan

免疫/内分泌

发表日期：2022

文献求助收藏

The (apparent) antibody paradox in COVID-19

新冠病毒中的（明显）抗体悖论

期刊:Expert Review of Clinical Immunology

影响因子:3.7

doi:10.1080/1744666X.2022.2044797

Ameratunga, Rohan; Woon, See-Tarn; Lea, Edward; Steele, Richard; Lehnert, Klaus; Leung, Euphemia; Brooks, Anna E S

Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19

常见变异型免疫缺陷病、T细胞对SARS-CoV-2疫苗的反应以及慢性COVID-19的风险

期刊:Journal of Allergy and Clinical Immunology-In Practice

影响因子:6.6

doi:10.1016/j.jaip.2021.06.019

Ameratunga, Rohan; Longhurst, Hilary; Steele, Richard; Lehnert, Klaus; Leung, Euphemia; Brooks, Anna E S; Woon, See-Tarn

Common Variable Immunodeficiency Disorders: A perspective from New Zealand

常见变异型免疫缺陷病：来自新西兰的视角

Opinion: the evolving understanding of polygenic common variable immunodeficiency-like disorders

观点：对多基因常见变异型免疫缺陷样疾病的认识不断加深

Phenotypic spectrum in a family with a novel RAC2 p.I21S dominant-activating mutation

具有新型 RAC2 p.I21S 显性激活突变的家族的表型谱

Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19

选择性IgA缺乏症可能是新冠肺炎重症的一个未被充分认识的风险因素

Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19

可溶性野生型ACE2分子能够抑制新型SARS-CoV-2变种，是一种潜在的抗病毒策略，可用于减轻COVID-19的疾病严重程度。

SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?

SARS-CoV-2 Omicron：是漫长疫情隧道尽头的曙光，还是免疫缺陷患者的又一次虚假希望？

First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Hypersensitivity Reaction

首例确诊的致命性暴发性坏死性嗜酸性粒细胞性心肌炎病例，发生于接种辉瑞-BioNTech mRNA COVID-19疫苗（BNT162b2，Comirnaty）首剂后：一种极其罕见的特异性超敏反应

Droplet digital PCR for identifying copy number variations in patients with primary immunodeficiency disorders

液滴数字PCR用于识别原发性免疫缺陷疾病患者的拷贝数变异

The (apparent) antibody paradox in COVID-19

新冠病毒中的（明显）抗体悖论

Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19

常见变异型免疫缺陷病、T细胞对SARS-CoV-2疫苗的反应以及慢性COVID-19的风险